Geoffrey R Lockhart, CRNA | |
611 Alcorn Dr, Corinth, MS 38834-9368 | |
(662) 293-7670 | |
(662) 293-4310 |
Full Name | Geoffrey R Lockhart |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 24 Years |
Location | 611 Alcorn Dr, Corinth, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629189949 | NPI | - | NPPES |
04522879 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | R853910 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Och Regional Medical Center | Starkville, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Och Professional Services | 9739252396 | 19 |
News Archive
"As the war on AIDS heads into its fourth decade, the need for funds is spiralling relentlessly higher, prompting a quest for new resources from consumer levies to contributions from developing giants," Agence France-Presse/France 24 reports (5/30).
China Medicine Corporation, primarily a manufacturer, leading distributor and developer of Western pharmaceuticals, traditional Chinese medicines, and other nutraceuticals, today announced its fourth quarter and full year 2009 results.
Factors known to be linked to schizophrenia risk have little predictive power at either the individual or population level, report researchers.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
› Verified 5 days ago
Entity Name | Och Professional Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225202666 PECOS PAC ID: 9739252396 Enrollment ID: O20080716000169 |
News Archive
"As the war on AIDS heads into its fourth decade, the need for funds is spiralling relentlessly higher, prompting a quest for new resources from consumer levies to contributions from developing giants," Agence France-Presse/France 24 reports (5/30).
China Medicine Corporation, primarily a manufacturer, leading distributor and developer of Western pharmaceuticals, traditional Chinese medicines, and other nutraceuticals, today announced its fourth quarter and full year 2009 results.
Factors known to be linked to schizophrenia risk have little predictive power at either the individual or population level, report researchers.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Geoffrey R Lockhart, CRNA Po Box 1818, Jackson, MS 39215-1818 Ph: (662) 293-7670 | Geoffrey R Lockhart, CRNA 611 Alcorn Dr, Corinth, MS 38834-9368 Ph: (662) 293-7670 |
News Archive
"As the war on AIDS heads into its fourth decade, the need for funds is spiralling relentlessly higher, prompting a quest for new resources from consumer levies to contributions from developing giants," Agence France-Presse/France 24 reports (5/30).
China Medicine Corporation, primarily a manufacturer, leading distributor and developer of Western pharmaceuticals, traditional Chinese medicines, and other nutraceuticals, today announced its fourth quarter and full year 2009 results.
Factors known to be linked to schizophrenia risk have little predictive power at either the individual or population level, report researchers.
NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.
› Verified 5 days ago
Mrs. Brooke Napier Hatchell, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000 | |
Amanda C Johnson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1440 Fax: 662-293-4334 | |
Lauren Elizabeth Cheek, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000 | |
Mr. Gary Keith Barnett, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1440 Fax: 662-293-4334 | |
Michael Mcnair, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000 | |
Tara Wadkins, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1440 Fax: 662-293-4334 | |
Mrs. April Renee Holley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000 |